Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Down 84.1% in June

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totaling 11 shares, a decline of 84.1% from the May 31st total of 69 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 1,322 shares, the short-interest ratio is currently 0.0 days.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

A number of hedge funds have recently modified their holdings of the business. Comprehensive Wealth Management LLC raised its holdings in Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after acquiring an additional 12,859 shares during the last quarter. Susquehanna International Group LLP increased its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares during the last quarter. Finally, Osaic Holdings Inc. lifted its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after buying an additional 597 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Trading Up 2.4%

BOUT stock opened at $48.85 on Friday. Innovator IBD Breakout Opportunities ETF has a 12-month low of $35.05 and a 12-month high of $49.41. The business’s 50-day moving average is $46.06 and its 200 day moving average is $41.49. The stock has a market cap of $17.10 million, a price-to-earnings ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.